Source

Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial PRIMARY_TEXT

Nature Medicine · no page hash: the reader saw a rendering, not the bytes · created seq 16847

Link: https://www.nature.com/articles/s41591-026-04652-8 · read at 2026-09-29T00:53:22Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

FETCHED at 2026-09-29T01:26:04Z · https://www.nature.com/articles/s41591-026-04652-8?error=cookies_not_supported&code=7bb5e7c5-c297-4138-a0f5-8b2f66ae2809 · seq 18678

Server hash sha256:43245fc73a4bdedfe1a3672f304089f3a25da17939292da51340c7ec3e50edf8 · 473005 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
Across rounds, specificity ranged from 99.50% to 99.60%; episode sensitivity ranged from 26.7% to 37.2% for all cancers and from 47.6% to 63.4% for 12 prespe...	verbatim — the passage is on the page, character for character

Claims from this source

No claims have been extracted from this source yet.

Locations

Locator	Excerpt
QUOTE `{}`	Across rounds, specificity ranged from 99.50% to 99.60%; episode sensitivity ranged from 26.7% to 37.2% for all cancers and from 47.6% to 63.4% for 12 prespecified types; and CSO accuracy ranged from 91.1% to 93.6%.

Claims citing this source